Market Overview

5 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • resTORbio, Inc. (NASDAQ: TORC) stock increased by 10.1% to $1.20 during Monday's pre-market session. The market value of their outstanding shares is at $264.2 million. The most recent rating by Cantor Fitzgerald, on November 15, is at Neutral, with a price target of $3.00.
  • Aurora Cannabis, Inc. (NYSE: ACB) shares increased by 3.9% to $2.83. The market cap stands at $4.8 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Qiagen, Inc. (NYSE: QGEN) shares rose 3.8% to $42.10. The market value of their outstanding shares is at $6.7 billion. The most recent rating by Stifel Nicolaus, on November 15, is at Hold, with a price target of $33.00.
  • Medicines Co, Inc. (NASDAQ: MDCO) stock surged 2.0% to $53.00. The market cap stands at $4.1 billion. The most recent rating by Jefferies, on October 10, is at Hold, with a price target of $50.00.

 

Losers

  • Phio Pharmaceuticals, Inc. (NASDAQ: PHIO) stock decreased by 4.7% to $0.18 during Monday's pre-market session. The market cap seems to be at $5.7 million.

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

 

Related Articles (MDCO + ACB)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

5 Technology Stocks Moving In Monday's Pre-Market Session

4 Observations From The First Ever 'Cannabis Investor Day'